Literature DB >> 353218

Trypanosoma cruzi: in vitro induction of macrophage microbicidal activity.

N Nogueira, Z A Cohn.   

Abstract

Normal, resident and inflammatory mouse peritoneal macrophages can be induced to display microbicidal activity against trypomastigotes of Trypanosoma cruzi by exposure to products from antigen-pulsed, sensitized spleen cell populations. Optimal macrophage microbicidal activity was achieved by constant exposure and daily renewal of the spleen cell factors. Macrophages obtained after an intraperitoneal injection of mild inflammatory agents were rapidly induced, displaying trypanocidal activity 24 h after exposure to the active spleen cell factor(s), and by 48 h, parasites were no longer observed. Resident peritoneal macrophages required 24 h longer for activation. Removal of the factor(s) before achieving complete disappearance of intracellular parasites led to resumed growth of the surviving organisms. The spleen cell factor(s) is effective when added either before or after exposure of the macrophages to trypomastigotes, and does not itself alter parasite viability. Dilution of the factor(s) up to 1:16 still results in significant trypanocidal activity. In vivo activated cells, obtained after a specific secondary challenge of animals infected with T. cruzi or Bacille Calmette-Guérin, lose their trypanocidal activity under in vitro conditions. This loss of activity can be prevented or restored by the addition of the active spleen cell factor(s). Induction of trypanocidal activity is also obtained with products from Concanavalin A- or lipopolysaccharide-stimulated normal spleen cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 353218      PMCID: PMC2184909          DOI: 10.1084/jem.148.1.288

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products.

Authors:  S E Anderson; S Bautista; J S Remington
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

2.  Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.

Authors:  L P Ruco; M S Meltzer
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Effect of human monocytes and macrophages on Trypanosoma cruzi.

Authors:  D M Williams; J S Remington
Journal:  Immunology       Date:  1977-01       Impact factor: 7.397

4.  Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity.

Authors:  H B Simon; J N Sheagren
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

5.  Effect of normal and activated human macrophages on Toxoplasma gondii.

Authors:  S E Anderson; J S Remington
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

6.  Trypanosoma cruzi: the immunological induction of macrophage plasminogen activator requires thymus-derived lymphocytes.

Authors:  N Nogueira; S Gordon; Z Cohn
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

7.  Trypanosoma cruzi: modification of macrophage function during infection.

Authors:  N Nogueira; S Gordon; Z Cohn
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

8.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

9.  Cellular resistance to infection.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

10.  THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY.

Authors:  Z A COHN; B BENSON
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

View more
  63 in total

Review 1.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Inhibition of growth of Listeria monocytogenes in vitro, by immunologically activated mouse resident macrophages.

Authors:  V L Krishnan; J H Humphrey
Journal:  Br J Exp Pathol       Date:  1986-12

3.  Cytochemical localization of NADH and NADPH oxidases during interaction of Trypanosoma cruzi with activated macrophages.

Authors:  T U de Carvalho; W de Souza
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

Review 4.  Effector cells, molecules and mechanisms in host-protective immunity to parasites.

Authors:  G F Mitchell
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

5.  Direct activation of human monocyte-derived macrophages by a bacterial glycoprotein extract inhibits the intracellular multiplication of virulent Legionella pneumophila serogroup 1.

Authors:  P Rajagopalan; E Dournon; J L Vildé; J J Pocidalo
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

6.  Rate and efficiency of complement-dependent phagocytosis in cytolytic and non-cytolytic inflammatory macrophages.

Authors:  A J Norin; R A De Pinho
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

7.  Role of iron in intracellular growth of Trypanosoma cruzi.

Authors:  V G Loo; R G Lalonde
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Minichromosomal repetitive DNA in Trypanosoma cruzi: its use in a high-sensitivity parasite detection assay.

Authors:  A Gonzalez; E Prediger; M E Huecas; N Nogueira; P M Lizardi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

10.  Activation of mouse peritoneal macrophages by maintenance in serum-free medium.

Authors:  L Walker; D B Lowrie; R Barclay; G Dixon; K Saunders; P W Andrew
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.